BMC urology · 2025
Transurethral resection of a giant bladder leiomyoma.
СтатьяКлинический случайVideo-Audio MediaНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deng Dihao, Li Jiaying, Luo Junhang, Liang Hui
Аннотация
BACKGROUND: Bladder leiomyomas are benign neoplasms of the bladder. Giant bladder leiomyomas are rare and conventionally treated by partial cystectomy.
CASE PRESENTATION: We present the case of a 51-year-old woman diagnosed with a bladder leiomyoma measuring 8.0 cm in diameter. The tumor was successfully removed through transurethral resection of bladder tumors (TURBT), which was completely recorded on video.
CONCLUSION: This case underscores the successful removal of a giant bladder leiomyoma by TURBT, resulting in a good prognosis. It highlights the potential for minimally invasive management strategies for benign neoplasms of the bladder.
TAKE-HOME INFORMATION: This case demonstrates that endoscopic resection of a giant bladder tumor is safe and feasible, offering a minimally invasive alternative for select patients.
CLINICAL TRIAL NUMBER: Not applicable.
CASE PRESENTATION: We present the case of a 51-year-old woman diagnosed with a bladder leiomyoma measuring 8.0 cm in diameter. The tumor was successfully removed through transurethral resection of bladder tumors (TURBT), which was completely recorded on video.
CONCLUSION: This case underscores the successful removal of a giant bladder leiomyoma by TURBT, resulting in a good prognosis. It highlights the potential for minimally invasive management strategies for benign neoplasms of the bladder.
TAKE-HOME INFORMATION: This case demonstrates that endoscopic resection of a giant bladder tumor is safe and feasible, offering a minimally invasive alternative for select patients.
CLINICAL TRIAL NUMBER: Not applicable.